MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO

CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN-3 AND METHODS FOR TREATING CANCER

Antibody and use thereof

HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODIES

TAU BINDING COMPOUNDS

VHH polypeptides that bind to toxin b and methods of use thereof

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN

SARS-COV-2 ANTIBODIES AND RELATED COMPOSITIONS AND METHODS OF USE

Anti-Varicella-Zoster Virus Antibody

HUMAN IL-15 MUTANT AND USES THEREOF

IMMUNOCONJUGATES

TREATING AND CURING COVID-19 INFECTION UTILIZING A LASER

ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT

Anti-TIGIT Antibodies

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

DNABII VACCINES AND ANTIBODIES WITH ENHANCED ACTIVITY

DICKKOPF2 (DKK2) INHIBITION SUPPRESSES TUMOR FORMATION

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS

COMPOSITIONS AND METHODS FOR AUGMENTING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPIES

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A PROGRAMMED DEATH-LIGAND 1 (PD-L1) INHIBITOR AND METHODS OF USE THEREOF

ANTIBODY AND PROTEIN FORMULATIONS

METHODS FOR TREATING BLADDER CANCER

HUMANIZED NOTCH RECEPTORS WITH HINGE DOMAIN

PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, CHOLANGIOCARCINOMA AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

ACTIVATABLE POLYPEPTIDE COMPLEX

THERAPEUTIC USE OF MITOCHONDRIA AND COMBINED MITOCHONDRIAL AGENTS

Subcutaneously administered anti-IL-6 receptor antibody

Anti-IL13R-alpha2 Antibodies, Antigen-Binding Fragments and Uses Thereof

ANTI-NR10 ANTIBODY AND USE THEREOF

METHODS FOR TREATING PRURIGO NODULARIS BY ADMINISTERING AN IL-4R ANTAGONIST

Antibody molecules and conjugates

ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODY AND USE THEREOF

HIF-1a MODULATORS AND USES THEREOF

Anti-CD11D antibodies and uses thereof

FC VARIANT AND PREPARATION THEREOF

BISPECIFIC ANTIBODY TARGETING HUMAN CLAUDIN AND HUMAN PDL1 PROTEINS, AND APPLICATION THEREOF

A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL

ANTI-PD1 ANTIBODIES AND METHODS OF USE

ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS AND INFECTIONS

METHODS OF USE OF ANTI-TREM2 ANTIBODIES

Compositions and Methods for Reducing Resistance to or Enhancing Immunotherapy

ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING ANEMIA OF CHRONIC DISEASE

COMPOSITION FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

COMBINATION THERAPY FOR TTR AMYLOIDOSIS

ANTIBODIES BINDING TO CITRULLINATED HISTONE 2A AND/OR 4

ENGINEERED ANTI-PROSTATE STEM CELL ANTIGEN FUSION PROTEINS AND USES THEREOF

EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF

METHOD OF TREATING INFLUENZA A

Anti-TIGIT Antibodies

METHODS OF TREATING INFECTIONS

ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY

FORMULATIONS WITH REDUCED OXIDATION

ACTIVATABLE POLYPEPTIDE COMPLEX

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF

Anti-CD98 Antibodies And Uses Thereof

Monoclonal Antibodies and Antigen Binding Fragments Thereof for Suppressing CD73 Immune Checkpoint and Uses Thereof

METHOD OF PROVIDING SAFE ADMINISTRATION OF AN ANTI-CD40 ANTIBODY

COMPOSITIONS COMPRISING AN ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME

Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof

Anti-TCR antibody molecules and uses thereof

Antibodies Binding to ILT4

DOSING REGIMEN FOR ANTI-DLL3 AGENTS

AFFINITY-MATURATED ANTI-ASIC1a ANTIBODIES

ANTI-ACTH ANTIBODIES AND USE THEREOF

METHODS AND COMPOSITIONS FOR MODULATING LIPID STORAGE IN ADIPOSE TISSUE

ANTI-C5 ANTIBODIES AND USES THEREOF

ANTI-NOVEL CORONAVIRUS MONOCLONAL ANTIBODY AND APPLICATION THEREOF

ANTI-TNF-a ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR AND USE THEREOF

Use of an RXR agonist in treating drug resistant HER2+ cancers

RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2

IMMUNOGLOBULIN VARIANTS

VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS

METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES

High concentration antibody-containing liquid formulation

ANTIBODIES BINDING IL6R AND USES THEREOF

ANTIBODY AND USES THEREOF

Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof

TREM2 STABILIZING ANTIBODIES

COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE ANGIOGENESIS

ANTI-CSP ANTIBODIES

High affinity antibodies targeting tau phosphorylated at serine 413

PSEUDOTYPED VIRUSES CONFIGURED TO EXPRESS CAR IN T-CELLS

CLOSTRIDIUM DIFFICILE ANTIGENS

Atomic description of immune complex that causes heparin-induced thrombocytopenia

ANTI-STEAP1 ANTIGEN-BINDING PROTEIN

Anti-CD5 antibodies and methods of use thereof

ADAM17 BINDING MOLECULES AND USES THEREOF

TRANSFERRIN RECEPTOR 1 TARGETING FOR CARCINOGENESIS PREVENTION

Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient

ANTIBODY MOLECULES

METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR

MULTISPECIFIC BINDING MOIETIES COMPRISING PD-1 AND TGF-BRII BINDING DOMAINS

AGENT, USES AND METHODS FOR TREATMENT

CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS

Anti-CD8 antibodies and uses thereof

METHODS OF USE OF ANTI-TREM2 ANTIBODIES

CD7 CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92MI CELL AND USE THEREOF

ANTI-G-CSF ANTIBODIES AND USES THEREOF

PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE

Anti-CGRP Antibody Formulation

ANTI-C5A ANTIBODIES

BLOCKADE OF IFN SIGNALING DURING CANCER VACCINATION

Conjugates of Biomolecule and Use Thereof

COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY

COMBINATION COMPRISING ALLOGENEIC IMMUNE CELLS DEFICIENT FOR AN ANTIGEN PRESENT ON BOTH T-CELLS AND PATHOLOGICAL CELLS AND THERAPEUTIC ANTIBODY AGAINST SAID ANTIGEN

IMMUNOACTIVATING ANTIGEN-BINDING MOLECULE

ANTI-CD73-ANTI-PD-1 BISPECIFIC ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CD9 AND CD137

OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IgG

Anti-OX40 antibody and uses thereof

METHODS AND COMPOSITIONS TO ENHANCE HUMORAL IMMUNITY TO REDUCE CYTOMEGALOVIRUS INFECTION AND REACTIVATION BY IL-6 INHIBITION

Method of Selecting Patients for Treatment with a Combination of an AXL Inhibitor and an Immune Checkpoint Modulator

COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS

Compositions and Methods for Vaccination and the Treatment of Infectious Diseases

METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURY

COMPOSITION COMPRISING AN IGE ANTIBODY

Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers

COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE

Combination Therapy with AXL Inhibitor and Immune Checkpoint Modulator or Oncolytic Virus

CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease

PHARMACEUTICAL FORMULATION COMPRISING A COMBINATION OF RECOMBINANT NEWCASTLE DISEASE VIRUSES FOR THE TREATMENT OF CANCER

Neoepitope immunotherapy with APC targeting unit

COMPOSITION AND METHOD FOR TREATING ALZHEIMER'S DISEASE

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY PULMONARY DISEASE

Fractionated radiotherapy and chemotherapy with an oxygen therapeutic

Cleavable tetrazine used in bio-orthogonal drug activation

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY

ANTI-PD1 ANTIBODIES AND METHODS OF USE

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS

CANCER THERAPEUTIC METHOD

ANTIBODIES TO MISFOLDED AMYLOID BETA

BASELINE SERUM AUTOANTIBODIES FOR PREDICTING RECURRENCE AND TOXICITY FOR IMMUNE CHECKPOINT BLOCKADE IN CANCER PATIENTS

COMPOSITIONS AND METHODS FOR TREATING CANCER

ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIB

TARGETING ALPHA3BETA1 INTEGRIN FOR TREATMENT OF CANCER AND OTHER DISEASES

Anti-CCL8 Antibodies and Treatment of Lung Injury by CCL8 Inhibition

Phage-displayed accessible recombinant targeted antibodies and methods of making same

Anti-MUC1 antibody-drug conjugate

SIRP-GAMMA TARGETED AGENTS FOR USE IN THE TREATMENT OF CANCER

Methods of treating gastrointestinal diseases characterized by inflammatory cells

ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF FIBROTIC DISEASES

Bispecific binding agents binding to CLDN18.2 and CD3

ANTIGEN BINDING PROTEINS

TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORME

Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer

Corticosteriod Reduction in Treatment with Anti-CD38 Antibody

GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

METHODS OF TREATING HER2 MUTANT CANCERS WITH TUCATINIB

ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF

Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta)

Immunoconjugates

Anti-TIGIT Antibodies

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED CANCER THERAPY

COMPOSITIONS AND METHODS FOR TREATING CANCER

Compositions and methods for cancer therapy

FABS-IN-TANDEM IMMUNOGLOBULIN AND USES THEREOF

COMBINATION THERAPY FOR TREATMENT OF A HEMATOLOGICAL DISEASE

ANTIBODIES SPECIFIC TO CTLA-4 AND USES THEREOF

METHODS FOR TREATING DYSREGULATED LIPID METABOLISM

ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS

Factor XI A2 domain-binding antibodies and methods of use thereof

USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS

Oncolytic virus strain

METHODS TO PREVENT, AMELIORATE AND TREAT COMPLICATIONS FROM VIRAL INFECTIONS

Cysteine Engineered Antibodies and Conjugates

Fusion proteins of GDF15 and use thereof

PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF

Site-specific antibody-drug conjugates by ADP-ribosyl cyclases

Selective immunodepletion of endogenous stem cell niche for engraftment

MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF

ANTI-IGF-1R ANTIBODIES AND USES THEREOF

COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ENHANCED EXPRESSION YIELD OF IMMUNOGLOBULIN A IN EUKARYOTES

ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF

ANTI-PACAP ANTIBODIES AND USES THEREOF

D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments

BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA

HETERODIMERIC PROTEINS WITH FC MUTATIONS

CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF

COMPLEMENT FACTOR Bb ANTIBODIES

TREATMENT OF IGE-MEDIATED DISEASES

Use of Brazikumab to Treat Crohn's Disease

Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods

ASTROTACTIN1-BASED COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS

STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL FORMULATIONS

PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES

ANTI-CCR8 ANTIBODIES FOR TREATING CANCER

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell

Bispecific antigen binding constructs targeting HER2

TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS BINDING TO PD-L1 AND CD137

B7-H4 ANTIBODY-DRUG CONJUGATES FOR THE TREATMENT OF CANCER

MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF

LONG-ACTING GM-CSF AND METHODS OF USE

NUCLEASE-SCAFFOLD COMPOSITION DELIVERY PLATFORM

METHODS FOR TREATING COLORECTAL AND METASTATIC COLORECTAL CANCERS

ANTI-EGFR ANTIBODY DRUG CONJUGATES

METHODS AND COMPOSITIONS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

MODULATING ANTI-TUMOR IMMUNITY

ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE

ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF

BINDING MOLECULE HAVING NEUTRALIZING ACTIVITY AGAINST SARS-CORONAVIRUS-2

PLASMA KALLIKREIN BINDING PROTEINS

Neutralizing anti-influenza binding molecules and uses thereof

USE OF EGFR/HER2 TYROSINE KINASE INHIBITORS AND/OR HER2/HER3 ANTIBODIES FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS

COMBINED USE OF CTB006 AND PONATINIB

Antibodies binding CD70, preparation and use thereof

ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE

METHOD OF TREATING AND PREVENTING OCULAR DISEASE WITH HSV-2 DELTA GD

METHODS OF TREATING CANCER WITH ANTI-PD-1 ANTIBODIES

RECOMBINANT FUSION PROTEINS TARGETING CD47 AND CD38, PREPARATION AND USE THEREOF

Antibodies binding CD24, preparation and use thereof

ANTIGEN-BINDING MOLECULES AND USES THEREOF

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

MuSK AGONIST ANTIBODY

USE OF ANTIBODY DRUG CONJUGATES COMPRISING TUBULIN DISRUPTING AGENTS TO TREAT SOLID TUMOR

ANTI-NGF ANTIBODY AND ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD, AND APPLICATION THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

HUMAN TARGETS

KRAS EPITOPES AND ANTIBODIES

Conditionally Active Anti-Her2 Antibodies, Antibody Fragments Their Immunoconjugates And Uses Thereof

METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES

Anti-IL1RAP antibody

MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

METHODS OF TREATING CANCER AND TUMOR-RELATED WEIGHT LOSS AND CACHEXIA

HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS

Antibody specific to spike protein of SARS-CoV-2 and uses thereof

ANTIBODIES BINDING IL4R AND USES THEREOF

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK

ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY OR PREVENTION OF SHOCK

ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF

CD38 MODULATING ANTIBODY AGENTS

SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY DIRECT INJECTION OF A TARGETED POPULATION OF CELLS

PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS

Methods and compositions for pretargeted immunotherapy

ANTI-TROP-2 ANTIDODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF

ANTI-TROP2 ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND APPLICATION OF THE SAME

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

PD1-BASED VACCINATION COMPOSITION AND METHODS THEREOF

TUNABLE EXTENDED RELEASE HYDROGELS

NEONATAL FC RECEPTOR BINDING AFFIMERS

ANTI-FCRH5 ANTIBODIES

ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-TM4SF1 ANTIBODIES AND METHODS OF USING THE SAME

MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY

HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR

ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF

CD137 BINDING MOLECULES AND USES THEREOF

HUMAN ANTI-GRP94 ANTIBODIES AND USES

COMBINATION THERAPY

Compositions and methods for delivery of nucleic acids to cells

COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) AND IMMUNE CHECKPOINT BLOCKERS

TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

NOVEL AGENTS AND USES THEREOF

Subcutaneous HER2 antibody formulations

NANOBODY FOR PCSK9 AND APPLICATION THEREOF

Compositions and methods of treating facioscapulohumeral muscular dystrophy

Selective drug release from internalized conjugates of biologically active compounds

Early intervention methods to prevent or ameliorate toxicity

TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION

PHARMACEUTICAL COMPOSITION

PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMENTIA

Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof

NOVEL ANTIBODIES

METHODS FOR TREATING IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNOSUPPRESSION

HUMANIZED MONOCLONAL ANTIBODY AGAINST cANGPTL4

ANTI-CD47/ANTI-PD-L1 ANTIBODY AND APPLICATIONS THEREOF

Anti-IL-2 Antibody, and Antigen-Binding Fragment Thereof and Medical Use Thereof

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

RELATED TARGET FOR TREATING FIBROTIC DISEASES AND APPLICATIONS THEREOF

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR TREATING CEREBRAL AMYLOID ANGIOPATHY

MULTI-SPECIFIC ANTIBODY WITH BINDING SPECIFICITY FOR HUMAN IL-13 AND IL-17

Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

ANTIBODY FRAGMENTS CONJUGATED TO PEG-PLGA NANOPARTICLES IMPROVE IMMUNOTHERAPY AGAINST CANCER CELLS

HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

4-1BBL TRIMER-CONTAINING ANTIGEN BINDING MOLECULES

TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN COMBINATION THERAPY

Chimeric Antigen Receptors Comprising Interleukin-9 Receptor Signaling Domain

METHODS AND SYSTEMS FOR DETERMINING PERSONALIZED THERAPIES

Engineered anti-il-2 antibodies

HUMAN ANTIBODIES THAT NEUTRALIZE ZIKA VIRUS AND METHODS OF USE THEREFOR

Compositions and methods for delivery of nucleic acids to cells

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

METHOD